Inventor · disambiguated record
Guobao Zhang
Also filed as: ZHANG GUOBAO
23 granted patents·20 pending applications·425 citations·filing 2000–2024
96Inventor score
Top patents by PatentIndex Score
43 records- 0196US7745437B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2005·Granted Jun 29, 2010·83 cites·8 claims
- 0296US7642255B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2008·Granted Jan 5, 2010·60 cites·6 claims
- 0395US11339162B1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0495US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 0591US8202876B2Compounds and compositions as protein kinase inhibitorsALBAUGH PAMELA·Filed 2007·Granted Jun 19, 2012·39 cites·9 claims
- 0689US8546396B2N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulatorsCHENG DAI·Filed 2010·Granted Oct 1, 2013·14 cites·18 claims
- 0786US8507491B2Compounds and compositions as hedgehog pathway inhibitorsCHENG DAI·Filed 2009·Granted Aug 13, 2013·11 cites·18 claims
- 0886US7868018B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2006·Granted Jan 11, 2011·11 cites·10 claims
- 0984US7371750B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted May 13, 2008·21 cites·7 claims
- 1083US10251893B2N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulatorsNOVARTIS AG·Filed 2017·Granted Apr 9, 2019·3 cites·12 claims
- 1183US6468522B1Controlled release of thioamide moiety-containing therapeutic agentsUNIV NEW JERSEY MED·Filed 2000·Granted Oct 22, 2002·13 cites·59 claims
- 1282US9238646B2N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as WNT signaling modulatorsCHENG DAI·Filed 2013·Granted Jan 19, 2016·5 cites·7 claims
- 1382US9181235B2Substituted pyridines for modulating the WNT signaling pathwayCHENG DAI·Filed 2011·Granted Nov 10, 2015·10 cites·15 claims
- 1480US11111249B2Heteroaryl-pyrazole derivative, and preparation method therefor and medical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Sep 7, 2021·3 cites·15 claims
- 1580US7846923B2Compounds and compositions as protein kinase inhbitorsIRM LLC·Filed 2007·Granted Dec 7, 2010·5 cites·6 claims
- 1678US11117898B2Pyrazolo-heteroaryl derivative, preparation method and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 14, 2021·3 cites·23 claims
- 1777US2024376099A1Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1875US9216964B2Hedgehog pathway modulatorsCHENG DAI·Filed 2013·Granted Dec 22, 2015·3 cites·18 claims
- 1974US8426404B2Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitorsZHANG GUOBAO·Filed 2006·Granted Apr 23, 2013·6 cites·15 claims
- 2070US11999728B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 2163US2021101902A1Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2262US2021380593A1Pyrazolo-heteroaryl derivative, preparation method and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2021·Application pending·0 cites
- 2361US10954233B2Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2017·Granted Mar 23, 2021·0 cites·30 claims
- 2452US2005124637A1Compounds and compositions as inhibitors of receptor tyrosine kinase activityIRM LLC·Filed 2004·Application pending·0 cites
- 2552US2013012704A1Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2012·Application pending·0 cites
- 2652US2013012476A1Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2012·Application pending·0 cites
- 2751US7045134B2Borellia burgdorferi epitope peptidesUNIV NEW JERSEY MED·Filed 2001·Granted May 16, 2006·0 cites·14 claims
- 2851US2016082014A1N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulatorsCHENG DAI·Filed 2015·Application pending·0 cites
- 2950US2011263610A1Compounds and compositions as itpkb inhibitorsIRM LLC·Filed 2009·Application pending·0 cites
- 3049US2010184765A1Protein Kinase Inhibitors and Methods for Using ThereofIRM LLC·Filed 2008·Application pending·0 cites
- 3148US2011053932A1Protein Kinase Inhibitors and Methods for Using ThereofIRM LLC·Filed 2008·Application pending·0 cites
- 3246US2009312321A1Compositions and methods for fgf receptor kinases inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 3346US2022041623A1Indole macrocyclic derivative, preparation method thereof and application thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 3445US12162879B2Pyridopyrimidine derivative, preparation method therefor and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 3544US2008188483A1Compounds and Compositions as Protein Kinase InhibitorsIRM LLC·Filed 2006·Application pending·0 cites
- 3644US2023142274A1Substituted aryl compoundSimcere pharmaceutical co ltd·Filed 2021·Application pending·0 cites
- 3744US2011092491A1Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase ActivityNOVARTIS AG·Filed 2010·Application pending·0 cites
- 3843US2005014753A1Novel compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Application pending·0 cites
- 3942US2003031674A1Poly (ethylene glycol) copolymersFiled 2001·Application pending·0 cites
- 4037US2003040127A1Multiple epitopes connected by a carrierFiled 2001·Application pending·0 cites
- 4137US2002106706A1Immunological test kit with borellia burgdorferi epitopeFiled 2001·Application pending·0 cites
- 4230US2002122785A1Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymersFiled 2002·Application pending·0 cites
- 4327US6913936B2Immunological test kit comprising an immunologically invisible peg copolymer conjugated to one or more immunologically reactive substancesUNIV NEW JERSEY MED·Filed 2001·Granted Jul 5, 2005·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Guobao Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →